PRDX2 protects hepatocellular carcinoma SMMC-7721 cells from oxidative stress

Zhou,Silei; Han,Quanli; Wang,Ru; Li,Xin; Wang,Qingyang; Wang,Huizhong; Wang,Jing; Ma,Yuanfang

doi:10.3892/ol.2016.4899

September-2016 Volume 12 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

September-2016 Volume 12 Issue 3

Full Size Image

Article

PRDX2 protects hepatocellular carcinoma SMMC-7721 cells from oxidative stress

Authors:
- Silei Zhou
- Quanli Han
- Ru Wang
- Xin Li
- Qingyang Wang
- Huizhong Wang
- Jing Wang
- Yuanfang Ma
View Affiliations / Copyright

Affiliations: Key Laboratory of Cellular and Molecular Immunology, Henan University, Kaifeng, Henan 475001, P.R. China, Department of Medical Oncology 2, Chinese PLA General Hospital & Chinese PLA Medical Academy, Beijing 100853, P.R. China, Clinical Laboratory, 305 Hospital of PLA, Beijing 100017, P.R. China, Department of Molecular Immunology, Institute of Basic Medical Sciences, Beijing 100850, P.R. China, Department of Radiation Oncology, Chinese PLA General Hospital & Chinese PLA Medical Academy, Beijing 100853, P.R. China
Pages: 2217-2221
|
Published online on: July 21, 2016

https://doi.org/10.3892/ol.2016.4899
Expand metrics +

Abstract

Peroxiredoxin2 (PRDX2) is a member of the peroxiredoxin family of antioxidant enzymes. A number of previous studies have indicated that PRDX2 may serve a cell type-dependent role in tumorigenesis. Recently, PRDX2 has been identified to be the new target of miR‑122a, which has been demonstrated to be frequently downregulated in hepatocellular carcinoma (HCC). Thus, PRDX2 may have a pro‑tumorigenic role in HCC. Because the role of PRDX2 in HCC has not yet been reported, it is of interest to explore how PRDX2 may affect reactive oxygen species (ROS)‑mediated cell death in HCC cells. The present study analyzed the effects of PRDX2 knockdown or overexpression on hydrogen peroxide (H2O2)‑induced cell death in HCC SMMC‑7721 cells. Tumor necrosis factor‑α (TNF‑α)‑induced cell death upon PRDX2 knockdown or overexpression was also examined in SMMC‑7721 cells. It was found that PRDX2 knockdown augmented H2O2‑induced cell death in SMMC‑7721 cells, whereas PRDX2 overexpression exhibited opposite effects. By contrast, PRDX2 knockdown enhanced TNF‑α‑induced apoptosis, whereas PRDX2 overexpression reduced it, even though both treatments showed little effects on TNF‑α‑induced necrosis in SMMC‑7721 cells. Further exploration confirmed PRDX2 knockdown led to enhanced ROS generation in response to H2O2. Taken together, the present study supports that PRDX2 serves a pro‑tumorigenic role in HCC through, at least partially, limiting ROS-mediated apoptosis under oxidative stress.

View Figures

View References

1	Llovet JM, Burroughs A and Bruix J: Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
2	Moon JC, Hah YS, Kim WY, Jung BG, Jang HH, Lee JR, Kim SY, Lee YM, Jeon MG, Kim CW, et al: Oxidative stress-dependent structural and functional switching of a human 2-Cys peroxiredoxin isotype II that enhances HeLa cell resistance to H2O2-induced cell death. J Biol Chem. 280:28775–28784. 2005. View Article : Google Scholar : PubMed/NCBI
3	Lu W, Fu Z, Wang H, Feng J, Wei J and Guo J: Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells' survival by protecting cells from oxidative stress. Mol Cell Biochem. 387:261–270. 2014. View Article : Google Scholar : PubMed/NCBI
4	Stresing V, Baltziskueta E, Rubio N, Blanco J, Arriba MC, Valls J, Janier M, Clézardin P, Sanz-Pamplona R, Nieva C, et al: Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs. Oncogene. 32:724–735. 2013. View Article : Google Scholar : PubMed/NCBI
5	Noh DY, Ahn SJ, Lee RA, Kim SW, Park IA and Chae HZ: Overexpression of peroxiredoxin in human breast cancer. Anticancer Res. 21:2085–2090. 2001.PubMed/NCBI
6	Kim K, Yu M, Han S, Oh I, Choi YJ, Kim S, Yoon K, Jung M and Choe W: Expression of human peroxiredoxin isoforms in response to cervical carcinogenesis. Oncol Rep. 21:1391–1396. 2009.PubMed/NCBI
7	Agrawal-Singh S, Isken F, Agelopoulos K, Klein HU, Thoennissen NH, Koehler G, Hascher A, Bäumer N, Berdel WE, Thiede C, et al: Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene. Blood. 119:2346–2357. 2012. View Article : Google Scholar : PubMed/NCBI
8	Furuta J, Nobeyama Y, Umebayashi Y, Otsuka F, Kikuchi K and Ushijima T: Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas. Cancer Res. 66:6080–6086. 2006. View Article : Google Scholar : PubMed/NCBI
9	Delhalle S, Deregowski V, Benoit V, Merville MP and Bours V: NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis. Oncogene. 21:3917–3924. 2002. View Article : Google Scholar : PubMed/NCBI
10	Diao S, Zhang JF, Wang H, He ML, Lin MC, Chen Y and Kung HF: Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma. Proteomics. 10:3723–3731. 2010. View Article : Google Scholar : PubMed/NCBI
11	Jin S, Ray RM and Johnson LR: TNF-alpha/cycloheximide-induced apoptosis in intestinal epithelial cells requires Rac1-regulated reactive oxygen species. Am J Physiol Gastrointest Liver Physiol. 294:G928–G937. 2008. View Article : Google Scholar : PubMed/NCBI
12	Christofferson DE, Li Y and Yuan J: Control of life-or-death decisions by RIP1 kinase. Annu Rev Physiol. 76:129–150. 2014. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

PRDX2 protects hepatocellular carcinoma SMMC-7721 cells from oxidative stress

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Related Articles